CRIS Current Research Information System

PALMERINI, TULLIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.265
AS - Asia 6.004
EU - Europa 4.091
AF - Africa 415
SA - Sud America 398
Continente sconosciuto - Info sul continente non disponibili 326
OC - Oceania 11
AN - Antartide 1
Totale 18.511
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.106
VN - Vietnam 1.916
SG - Singapore 1.525
CN - Cina 1.305
GB - Regno Unito 886
IT - Italia 685
DE - Germania 574
SE - Svezia 490
HK - Hong Kong 404
BR - Brasile 266
FR - Francia 263
IN - India 252
UA - Ucraina 226
RU - Federazione Russa 193
IE - Irlanda 170
NL - Olanda 170
JP - Giappone 111
CI - Costa d'Avorio 103
KR - Corea 93
ZA - Sudafrica 88
BD - Bangladesh 81
CA - Canada 79
CH - Svizzera 75
FI - Finlandia 75
SC - Seychelles 73
BG - Bulgaria 68
EE - Estonia 63
TG - Togo 62
JO - Giordania 54
NG - Nigeria 54
PH - Filippine 51
AR - Argentina 48
MX - Messico 34
IQ - Iraq 30
EC - Ecuador 28
BE - Belgio 27
TH - Thailandia 26
AT - Austria 25
PL - Polonia 25
IR - Iran 24
CO - Colombia 21
TR - Turchia 18
ES - Italia 16
PK - Pakistan 15
TW - Taiwan 13
CL - Cile 12
EG - Egitto 12
ID - Indonesia 12
LT - Lituania 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
MY - Malesia 11
HN - Honduras 9
RO - Romania 9
AU - Australia 8
CR - Costa Rica 8
JM - Giamaica 8
PY - Paraguay 7
GR - Grecia 6
HR - Croazia 6
OM - Oman 6
TN - Tunisia 6
DK - Danimarca 5
KZ - Kazakistan 5
NP - Nepal 5
PE - Perù 5
GT - Guatemala 4
LV - Lettonia 4
PT - Portogallo 4
SV - El Salvador 4
UY - Uruguay 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
KE - Kenya 3
LB - Libano 3
MA - Marocco 3
MN - Mongolia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
ET - Etiopia 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ML - Mali 2
MQ - Martinica 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
SI - Slovenia 2
AL - Albania 1
AQ - Antartide 1
BW - Botswana 1
DZ - Algeria 1
Totale 18.171
Salva come PNG Salva come JPEG
Città #
Singapore 1.067
Ashburn 780
Southend 719
Fairfield 544
San Jose 485
Ho Chi Minh City 437
Chandler 436
Hanoi 383
Hong Kong 377
Santa Clara 316
Wilmington 250
Woodbridge 249
Seattle 242
Houston 234
Princeton 214
Council Bluffs 194
Beijing 191
Cambridge 185
Dong Ket 182
Ann Arbor 176
Dublin 169
Hefei 168
New York 151
Jacksonville 150
Boardman 143
Los Angeles 112
Abidjan 102
Bologna 99
Lauterbourg 96
Tokyo 88
Westminster 80
Padova 71
Da Nang 69
Berlin 68
Bern 68
Milan 67
Turin 67
Sofia 64
Lomé 62
Nanjing 62
Seoul 61
Buffalo 60
Chicago 59
Amman 54
Bremen 54
Haiphong 54
Abeokuta 53
Dallas 52
Munich 50
Frankfurt am Main 47
Helsinki 47
The Dalles 43
São Paulo 41
Saint Petersburg 38
Jinan 37
San Diego 35
Redondo Beach 32
Guangzhou 31
Rome 31
Nanchang 30
Mülheim 29
Shanghai 29
Changsha 28
London 27
Biên Hòa 26
Brussels 26
Phoenix 25
Johannesburg 24
Tianjin 23
Dearborn 22
Medford 22
Pune 21
Shenyang 21
Falkenstein 20
Turku 20
Yubileyny 20
Can Tho 19
Florence 19
Quận Bình Thạnh 19
Toronto 19
Jiaxing 18
Lanzhou 18
Atlanta 17
Des Moines 17
Hebei 17
Mahé 17
Montreal 17
Washington 17
Zhengzhou 17
Falls Church 16
Orem 16
Pisa 16
Vienna 16
Warsaw 16
Baghdad 15
Denver 15
Thái Nguyên 15
Verona 15
Bengaluru 14
Ha Long 14
Totale 11.308
Salva come PNG Salva come JPEG
Nome #
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 291
A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study. 279
The role of the vascular surgeon in transcatheter aortic valve implantation 275
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 273
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 264
Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction 254
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. 252
A randomised comparison between clopidogrel 150 mg daily maintenance dose versus 75 mg in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention 246
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 239
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 238
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 236
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 229
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 222
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system 218
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 216
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 215
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 214
In vitro thrombogenicity of drug-eluting and bare metal stents 214
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 213
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 207
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 204
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 200
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients 200
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 198
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 198
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 196
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 194
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 194
Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm 193
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 193
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 193
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged ³ 75 years) 191
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 190
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 190
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction 190
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). 185
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 185
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 184
Preprocedural Levels of C-Reactive Protein and Leukocyte Counts Predict 9-Month Mortality After Coronary Angioplasty for the Treatment of Unprotected Left Main Coronary Artery Stenosis. 183
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 183
Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention. 182
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 180
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 179
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 176
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting 176
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 175
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 175
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study 172
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 170
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 169
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 169
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 168
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 168
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 167
Defining high-risk patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention: A comparison among different scoring systems and clinical definitions 167
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. 167
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 166
Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials. 165
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 165
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: An individual patient data pairwise and network meta-analysis 164
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 163
Residual aortic regurgitation is a major determinant of late mortality after transcatheter aortic valve implantation 162
Recapture of the Sapien-3 Delivery System After Transversal Balloon Rupture Using a Whole Percutaneous Femoral Approach 162
Percutaneous revascularization of left main: Role of imaging, techniques and adjunct pharmacology 159
Predictors of beta-brachytherapy failure in patients with high-risk in-stent restenosis 158
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 157
Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. 156
Correlation between aortic root dimension and coronary ectasia 156
Coronary ectasia in different scenarios, primarily in myocardial infarction with nonobstructive coronary artery disease 154
Risk of stroke in patients with high on clopidrogel platelet reactivity to ADP after percutaneous coronary intervention: systematic review and meta-analysis 154
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 154
Routine minimalist transcatheter aortic valve implantation with local anesthesia only 154
Ruolo del fattore tissutale circolante nel determinare la trombosi di stent in un sistema di perfusione in vitro. 151
Sino-tubular junction to sinuses of Valsalva ratio: An echocardiographic parameter to predict coronary artery ectasia in patients with aortic enlargement 151
Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. 149
Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial 148
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 148
Description of an In-vitro of Stent Perfusion to Study Stent Thrombosis at Different Shear Rates 147
Early invasive strategy (< 24 hours) in patients with acute coronary syndromes: Weighing the evidence 146
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. 146
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk 144
Impact of coronary bypass or stenting on mortality and myocardial infarction in stable coronary artery disease 141
Risk-benefit profile of longer-than-1-year dual-antiplatelet therapy duration after drug-eluting stent implantation in relation to clinical presentation a pairwise meta-analysis of 6 trials and 21 457 patients 140
Reply: Can We State That Placing a Stent Is Sufficient? 140
Prognostic importance of ventricular arrhythmia in patients treated with percutaneous coronary intervention. 138
Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty 138
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis of 21 Randomized Trials and 32,524 Patients 135
Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial 132
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry 130
Coronary Stent Infection and Subsequent Abscessualization Causing Dislocation in Extravascular Position 125
Biolimus-a9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 123
Surgical risk scores applied to transcatheter aortic valve implantation: Friends or foes? short-term and long-term outcomes from a single-center registry 122
Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement 122
Risk of Stroke of Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease: a Systematic Review and Meta-analysis of Contemporary Randomized Clinical Trials 121
Predictors of bail-out stenting in patients with small vessel disease treated with drug-coated balloon percutaneous coronary intervention 120
Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation in a Large and Noncalcified Annulus 119
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial. 118
Efficacia a lungo termine della brachiterapia endocoronarica beta (32P) nel trattamento delle ristenosi intrastent ad elevato rischio. Risultati prospettici di un registro monocentrico 114
Off-Label Use of Balloon-Expandable Transcatheter Valves to Treat Pure Aortic Regurgitation 113
Reduced Mortality With Antiplatelet Therapy Deescalation After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Meta-Analysis 112
Totale 17.681
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.416 0 0 0 164 137 93 35 126 54 130 380 297
2022/20232.185 196 266 128 254 173 179 55 123 394 71 208 138
2023/2024622 46 84 31 78 53 206 19 28 14 34 13 16
2024/20252.497 124 375 196 189 426 162 98 68 30 207 85 537
2025/20266.220 697 598 462 454 634 318 718 281 1.188 464 206 200
2026/20271.101 110 219 422 350 0 0 0 0 0 0 0 0
Totale 18.511